SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0000950170-24-057131
Filing Date
2024-05-09
Accepted
2024-05-09 16:34:19
Documents
15
Period of Report
2024-05-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A eftr-20240509.htm   iXBRL 8-K/A 59511
2 EX-3.1 eftr-ex3_1.htm EX-3.1 383995
3 EX-5.1 eftr-ex5_1.htm EX-5.1 28893
4 GRAPHIC img152111001_0.jpg GRAPHIC 9054
5 GRAPHIC img152111001_1.jpg GRAPHIC 58631
  Complete submission text file 0000950170-24-057131.txt   790206

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT eftr-20240509.xsd EX-101.SCH 56336
18 EXTRACTED XBRL INSTANCE DOCUMENT eftr-20240509_htm.xml XML 6552
Mailing Address 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075
Business Address 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075 (858) 925-8215
eFFECTOR Therapeutics, Inc. (Filer) CIK: 0001828522 (see all company filings)

IRS No.: 853306396 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-39866 | Film No.: 24931333
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)